Noah Agada
Impact in
- Dermatology top 5%
- Dermatology and Skin Diseases
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis
- Immunodeficiency and Autoimmune Disorders
Papers in
- Immunology 12
- Psoriasis: Treatment and Pathogenesis 10
- Immunodeficiency and Autoimmune Disorders 3
-
- Microscopic Colitis 3
- Co-authors
- Kristian Reich (6 shared papers)Melinda Gooderham (5 shared papers)Andrew Blauvelt (5 shared papers)Susan Ball (4 shared papers)Lars Iversen (2 shared papers)Lu Zhang (1 shared paper)Richard G. Langley (2 shared papers)Wen Xu (4 shared papers)
- Journals
- Journal of the American Academy of Dermatology (2 papers)Dermatology and Therapy (2 papers)Journal of Investigative Dermatology (2 papers)Academic Emergency Medicine (2 papers)Journal of Crohn s and Colitis (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Noah Agada
20 papers receiving 419 citations
Peers
Comparison fields: 5 of 66
- Dermatology 161
- Immunology 297
- Rheumatology 80
- Hematology 47
- Emergency Medicine 31
Countries citing papers authored by Noah Agada
This map shows the geographic impact of Noah Agada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noah Agada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noah Agada more than expected).
Fields of papers citing papers by Noah Agada
This network shows the impact of papers produced by Noah Agada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noah Agada. The network helps show where Noah Agada may publish in the future.
Co-authors
The 25 scholars most cited alongside Noah Agada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 93 | |
| 2 | 2019 | 54 | |
| 3 | 2018 | 48 | |
| 4 | 2018 | 46 | |
| 5 | 2011 | 36 | |
| 6 | 2020 | 34 | |
| 7 | 2019 | 23 | |
| 8 | Safety and Tolerability of Ixekizumab: Integrated Analysis of Injection-Site Reactions from 11 Clinical Trials. | 2018 | 19 |
| 9 | 2011 | 18 | |
| 10 | 2020 | 12 | |
| 11 | Diabetes care in Nigeria: time for a paradigm shift. | 2006 | 9 |
| 12 | Microalbuminuria and clinical correlates in black African patients with type 2 diabetes. | 2007 | 9 |
| 13 | 2023 | 8 | |
| 14 | 2017 | 5 | |
| 15 | 2020 | 4 | |
| 16 | 2023 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2017 | 2 | |
| 19 | 2015 | 2 | |
| 20 | 2023 | 1 |
About Noah Agada
Noah Agada is a scholar working on Immunology, Epidemiology, Genetics, Dermatology and Pediatrics, Perinatology and Child Health, having authored 20 papers that have together received 431 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (10 papers), Inflammatory Bowel Disease (5 papers), Dermatology and Skin Diseases (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Pharmaceutical studies and practices (3 papers), Microscopic Colitis (3 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Emergency and Acute Care Studies (2 papers). The work is most often cited by research in Dermatology (161 citations), Immunology (297 citations), Rheumatology (80 citations), Hematology (47 citations) and Emergency Medicine (31 citations). Noah Agada has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Kristian Reich, Melinda Gooderham, Andrew Blauvelt, Susan Ball, Lars Iversen, Lu Zhang, Richard G. Langley, Wen Xu, Kim Papp and Melissa L. McCarthy. Their work appears in journals such as Journal of the American Academy of Dermatology, Dermatology and Therapy, Journal of Investigative Dermatology, Academic Emergency Medicine and Journal of Crohn s and Colitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.